The United States ophthalmic market is witnessing robust growth driven by an increasing aging population and rising prevalence of eye disorders. Advancements in technology combined with expanding healthcare infrastructure underscore significant opportunities for market players. The integration of innovative therapies and devices is shaping the industry share and competitive landscape dynamically.

Market Size and Overview

The global United States ophthalmic market size is estimated to be valued at USD 18.82 billion in 2025 and is expected to reach USD 33.97 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032. This United States Ophthalmic Market forecast reflects strong market drivers such as increased incidence of retinal diseases and glaucoma, along with rising demand for ophthalmic surgical devices. These factors directly influence the market revenue and underline the evolving market trends documented in the latest market report.

Investment Scenario Investment activity in the United States ophthalmic market has surged in 2025, particularly in research and development for advanced drug delivery systems and minimally invasive surgical tools. Venture capital interest has accelerated, with recent funding rounds exceeding USD 500 million dedicated to novel ophthalmic treatments. M&A activities have intensified, exemplified by AbbVie’s increased capital allocation toward expanding its ophthalmology portfolio and strategic acquisitions aimed at broadening regional production hubs. Such investments are reshaping the market dynamics and offering lucrative market opportunities.

United States Ophthalmic Market - https://www.coherentmi.com/industry-reports/united-states-ophthalmic-market